Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
238
-
Total 13F shares, excl. options
-
85.7M
-
Shares change
-
+939K
-
Total reported value, excl. options
-
$4.34B
-
Value change
-
+$54.6M
-
Put/Call ratio
-
0.24
-
Number of buys
-
119
-
Number of sells
-
-107
-
Price
-
$50.64
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q3 2016
280 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q3 2016.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 238 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.7M shares
of 99.6M outstanding shares and own 86.04% of the company stock.
Largest 10 shareholders include FMR LLC (13M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.36M shares), VANGUARD GROUP INC (6.29M shares), BB BIOTECH AG (3.12M shares), Invesco Ltd. (2.6M shares), PERCEPTIVE ADVISORS LLC (2.48M shares), BlackRock Institutional Trust Company, N.A. (2.15M shares), STATE STREET CORP (2.14M shares), JANUS CAPITAL MANAGEMENT LLC (2.13M shares), and FRANKLIN RESOURCES INC (2.01M shares).
This table shows the top 238 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.